Real-world evidence on palmoplantar pustulosis: Patient characteristics, diagnostic challenges and predictive factors for treatment survival - a retrospective registry study - Articles - Dermatology · Immunology · Rheumatology

Melanoma and Skin Cancer

A national cohort study of melanoma BRAF status, testing patterns, patient and tumour characteristics, treatment and survival in England 2016-21

Br J Dermatol

Mistry K, Jeffrey P, Levell NJ, Kennedy O, Richardson K, Craig P, Bright C, Taylor S, Ragan J, Karponis D, Pethick J, Lavelle K, McRonald F, Hardy S, Vernon S, Lorigan P, Venables ZC

doi: 10.1093/bjd/ljaf351

Melanoma and Skin Cancer

Survival outcomes and response to immune checkpoint inhibitors among patients with advanced Merkel cell carcinoma: a retrospective study of 81 patients

Ann Dermatol Venereol

David C, Coquelle C, Le Corre Y, L'Orphelin JM, Nardin C, Aubin F, Cassecuel J, Dreno B, Wierzbiecka-Hainault E, Bens G, Beneton N, Dinulescu M, Kervarrec T, Saiag P, Blom A, Samimi M

doi: 10.1016/j.annder.2025.103411

Atopic Dermatitis

Baseline characteristics of atopic eczema patients enrolled in seven European registries united in the TREatment of ATopic eczema (TREAT) registry taskforce

J Eur Acad Dermatol Venereol

Musters AH, Gerbens LAA, van der Gang L, Middelkamp-Hup MA, Ouwerkerk W, Hijnen DJ, Haufe E, Heinrich L, Werfel T, Weidinger S, Schmitt J, Svedbom A, Johansson EK, Bradley M, von Kobyletzki LB, Vittrup I, Ruge IF, Thyssen JP, Vestergaard C, Carrascosa JM, de Vega M, García-Doval I, Chiricozzi A, Stingeni L, Calzavara-Pinton P, Ardern-Jones MR, Reynolds NJ, Flohr C, Spuls PI, A‐STAR, AtopyReg, BIOBADATOP, SCRATCH, SwedAD, TREATgermany and TREAT NL/BE registry teams

doi: 10.1111/jdv.20876

Rheumatoid Arthritis

Achievement of treatment targets and maintenance of response with upadacitinib in patients with moderate-to-severe rheumatoid arthritis in real-world practice: 1-year outcomes from the UPHOLD observational study

Arthritis Res Ther

Östör A, Feist E, Sidiropoulos P, Avouac J, Rebella M, Namas R, McDearmon-Blondell E, Gao T, Lagunes-Galindo I, Strengholt S, Zisman D, Attar S

doi: 10.1186/s13075-025-03528-5

Psoriasis

Drug survival of systemic treatments for severe paediatric psoriasis: An international retrospective study

J Eur Acad Dermatol Venereol

Miao Y, Beauchet A, Piram M, McPherson T, Torres T, Yesli Y, Aubert H, Bodemer C, Bertoli C, Tardieu M, Hubiche T, Bonniaud B, Neri I, Chessa MA, Lasek A, Prignano F, Barbarot S, Bursztejn AC, Leducq S, Sergeant M, Puzenat E, Chiaverini C, Sigg N, Mallet S, Miquel J, Pourchot D, Patel KX, Burden-Teh E, Flohr C, Di Lernia V, Mahé E, GrPso of the Société Française de Dermatologie; Groupe de Recherche de la Société Française de Dermatologie Pédiatrique

doi: 10.1111/jdv.70108

Rheumatoid Arthritis

Prospective study on mental status in rheumatoid arthritis patients on tumour necrosis factor vs non- tumour necrosis factor-targeted therapies after achieving treatment target

Rheumatology (Oxford)

Fujii T, Murata K, Nakabo S, Onishi A, Murakami K, Tanaka M, Morinobu A, Matsuda S

doi: 10.1093/rheumatology/keaf598

PsoriasisPsoriatic ArthritisFurther Publications Rheumatology

Real-World Evidence for Ixekizumab in the Treatment of Psoriasis, Psoriatic Arthritis, and Axial Spondyloarthritis: Systematic Literature Review 2022-2023

Adv Ther

Puig L, Sewerin P, Schuster C, Ng KJ, Papadimitropoulos M, Gadagamma S, Nuñez M, Lampropoulou A

doi: 10.1007/s12325-025-03258-9

Further Publications Rheumatology

Real-world data on treatment persistence and measures to minimize cardiovascular risk in rheumatic patients using upadacitinib

Rheumatology (Oxford)

Hernández-Hernández MV, García-Dorta A, Rodríguez-Regalado C, Hernández-Martín A, Naveda-González E, Martínez-González C, Peña-Montelongo S, Rodríguez Lozano C, González-Dávila E, Díaz-González F

doi: 10.1093/rheumatology/keaf547

Rheumatoid Arthritis

Multicenter Study of Secukinumab Uptitration in Axial Spondyloarthritis: Real-World Evidence

J Rheumatol

Freites Núñez D, Gallego A, García Dorta A, García-Valle A, Valero Expósito M, De la Morena Barrio I, Arconada C, Valero C, Fernández-Prada M, López I Gómez M, Álvarez de Cienfuegos A, López-Sánchez R, García Martos Á

doi: 10.3899/jrheum.2025-0102

Related content

A national cohort study of melanoma BRAF status, testing patterns, patient and tumour characteristics, treatment and survival in England 2016-21

Survival outcomes and response to immune checkpoint inhibitors among patients with advanced Merkel cell carcinoma: a retrospective study of 81 patients

Baseline characteristics of atopic eczema patients enrolled in seven European registries united in the TREatment of ATopic eczema (TREAT) registry taskforce

Achievement of treatment targets and maintenance of response with upadacitinib in patients with moderate-to-severe rheumatoid arthritis in real-world practice: 1-year outcomes from the UPHOLD observational study

Drug survival of systemic treatments for severe paediatric psoriasis: An international retrospective study

Prospective study on mental status in rheumatoid arthritis patients on tumour necrosis factor vs non- tumour necrosis factor-targeted therapies after achieving treatment target

Real-World Evidence for Ixekizumab in the Treatment of Psoriasis, Psoriatic Arthritis, and Axial Spondyloarthritis: Systematic Literature Review 2022-2023

Real-world data on treatment persistence and measures to minimize cardiovascular risk in rheumatic patients using upadacitinib

Multicenter Study of Secukinumab Uptitration in Axial Spondyloarthritis: Real-World Evidence